| Active Market | Forge Price1 | Last Funding Round | Trade Eligibility | ||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Company | Sector & Subsector | Market Activity4   |
Highest Bid | Lowest Ask | Last Matched | +/- to LFR | $ Total Bids |
$ Total Asks |
# Bids |
# Asks |
Current Price |
6-month |
1-year |
Total Funding |
Round | Date | Amount Raised |
Post-Money Valuation3 |
Price |
Key Investors | Common | Preferred | Fund | ||
 | Ratio Therapeutics | Healthcare Other Healthcare | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $151.27M | Series C | 7/31/2026 | $70M | $398.34M | $43.69 | Duquesne Family Office, Bristol Myers Squibb, Catalio Capital Management, Eli Lilly and Company, Wasatch Group | ||||
 | Sandstone | Enterprise Software Productivity | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $41.3M | Series A-1 | 6/9/2026 | $30.41M | $240.07M | $11.56 | Lightspeed Venture Partners, Sequoia Capital, Kearny Jackson, SV Angel, Webb Investment Network, Mantis VC, Antiportfolio Ventures, Daybreak Ventures, Operator Partners, Killer Whale Strategies, Litquidity Capital, Zach Abramowitz, Freddy Kerrest, Scott McNealy, Raji Arasu | ||||
 | Sapiom | Fintech Fintech Software | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $47.94M | Series A-1 | 8/5/2026 | $32.62M | $284.15M | $15.16 | Dragonfly, Accel, Gradient, Coinbase Ventures, Operator Collective, Formus Capital, VanEck Ventures, Okta Ventures, Menlo Ventures, Anthropic, Array Ventures | ||||
 | Self Labs | Enterprise Software Software Development | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | -- | Not available | -- | -- | -- | -- | -- | ||||
 | Singularity | Industrial Aerospace & Defense | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $110.59M | Series A-1 | 7/14/2026 | $74.72M | $400M | $11.53 | Khosla Ventures, Felicis, AE Ventures, NEA, Long Journey, Harpoon, Menlo Ventures, Y Combinator, Decisive Point, New Vista Capital, Sunflower Capital, Soma Capital | ||||
 | SonoSuite | Consumer & Lifestyle Entertainment | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | -- | Not available | -- | -- | -- | -- | -- | ||||
 | Terramtech | Industrial Other Industrial | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $57.55M | Series A-4 | 6/16/2026 | $14M | $503.69M | $22.81 | Undisclosed Investors | ||||
 | Thrive Holdings | Enterprise Software Business Operations | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | -- | Not available | -- | -- | -- | -- | -- | ||||
 | TwinStrand Biosciences | Healthcare Biotech & Pharma | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | -- | Not available | -- | -- | -- | -- | -- | ||||
 | Warp | Enterprise Software Productivity | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | -- | Not available | -- | -- | -- | -- | -- | ||||
 | Zetagen Therapeutics | Healthcare Biotech & Pharma | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | -- | Not available | -- | -- | -- | -- | -- | ||||
 | Adaptive Innovations | Healthcare Other Healthcare | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $60M | Series A | 6/2/2026 | $50M | $242.97M | $6.26 | Felicis, Optum Ventures, Sunflower Capital, Conviction, BoxGroup, SV Angel, Dorm Room Fund, Constellation, Bain Capital Ventures | ||||
 | Allotera Therapeutics | Healthcare Other Healthcare | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $322.92M | Series C | 7/23/2026 | $83.2M | $291.45M | $1.77 | Fidelity, RiverVest Venture Partners, Lightchain Capital, LYZZ Capital, Abingworth, Intermediate Capital Group, Tybourne Capital Management, Aisling Capital Management, BioGenerator Ventures, Sands Capital, Alexandria Venture Investments, Velosity Capital, Falcon Edge Capital | ||||
 | Arria Nlg | Enterprise Software Business Operations | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | -- | Not available | -- | -- | -- | -- | -- | ||||
 | Aulos | Healthcare Biotech & Pharma | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | -- | Not available | -- | -- | -- | -- | -- | ||||
 | Biobot Analytics | Healthcare Digital Health | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | -- | Not available | -- | -- | -- | -- | -- | ||||
 | Cardinal Data Power | Energy Other Energy | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $70M | Series A-1 | 7/23/2026 | $54.05M | $318.74M | $1.44 | Hood River Capital Management, Empery Digital | ||||
 | Earnest Analytics | Fintech Personal Finance | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | -- | Not available | -- | -- | -- | -- | -- | ||||
 | Expedition Therapeutics | Healthcare Other Healthcare | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $280M | Series B | 8/5/2026 | $115M | $599.82M | $7.43 | General Atlantic, RA Capital, Vivo Capital, Novo Holdings, Sofinnova Investments, Forbion, Dawn Biopharma, Venrock, Sanofi Ventures, Logos Capital, Biotechnology Value Fund, Balyasny, Adage | ||||
 | Georgiamune | Healthcare Other Healthcare | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $167.69M | Series B-1 | 7/16/2026 | $64.09M | $407.96M | $11.11 | Undisclosed Investors | ||||
 | Meshy | Consumer & Lifestyle Media | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | -- | Not available | -- | -- | -- | -- | -- | ||||
 | Mirendil | Consumer & Lifestyle Other Consumer & Lifestyle | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | -- | Not available | -- | -- | -- | -- | -- | ||||
 | RNAimmune | Healthcare Biotech & Pharma | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | -- | Not available | -- | -- | -- | -- | -- | ||||
 | Simile | Enterprise Software Productivity | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $300M | Series B | 7/30/2026 | $200M | $2B | $90.10 | Greenoaks, Index Ventures, Hanabi Capital, Bain Capital Ventures, A*, Factory Capital, CVS Health Ventures, Definition | ||||